Griffonia simplicifolia

Reported Doses

Safety/efficacy may not be established; reported doses may be derived from limited or potentially inadequate studies w/ variable regimens, multi-ingredient products, or where concentration of active ingredients may vary widely

Effectiveness Ratings

[see Herb & Supplement Effectiveness Rating Definitions table]

alcohol withdrawal sx

[Insufficient Evidence]

Dose: 5 mg PO qd

anxiety

[Insufficient Evidence]

Dose: 25-150 mg PO qd; Info: used w/ peripheral decarboxylase inhibitor

cerebellar ataxia

[Insufficient Evidence]

Dose: 10 mg/kg/dose PO qd

depression

[Possibly Effective]

Dose: 150-800 mg PO qd; Info: up to 3000 mg/day has been used

fibromyalgia

[Insufficient Evidence]

Dose: 100 mg PO tid

migraine prophylaxis

[Insufficient Evidence]

Dose: 600 mg PO qd

obesity

[Insufficient Evidence]

Dose: 250-300 mg PO tid; Info: give 30min before meals

obsessive-compulsive disorder

[Insufficient Evidence]

Dose: 200 mg PO qd; Info: used w/ selective serotonin reuptake inhibitor

opioid withdrawal sx

[Insufficient Evidence]

Dose: 200 mg PO qd

Parkinson dz

[Insufficient Evidence]

Dose: 50 mg PO qd; Info: used w/ peripheral decarboxylase inhibitor